Omeros (OMER) Payables (2010 - 2026)
Omeros (OMER) posted Payables of $5.4 million for Q1 2026, up 12.66% sequentially from $4.8 million in Q4 2025, and up 21.62% YoY from $4.4 million in Q1 2025.
Omeros (OMER) Payables (2010 - 2026) Analysis & Trends
Omeros has reported Payables for 17 years, with the latest figure at $5.4 million in Q1 2026.
- Quarterly Payables rose 21.62% year-over-year to $5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.4 million (up 21.62% YoY) and the FY2025 annual result came in at $4.8 million, down 19.32% from the prior year.
- Payables rose to $5.4 million in Q1 2026 per OMER's latest filing, from $4.8 million in the prior quarter.
- Over five years, Payables peaked at $17.1 million in Q3 2022 and troughed at $4.4 million in Q1 2025.
- A 5-year average of $7.8 million and a median of $6.5 million in 2024 frame the typical range for Payables.
- The sharpest annual moves came in 2022 and 2023: Payables jumped 70.45% in 2022, then slumped 65.67% in 2023.
- Over 5 years, Payables stood at $6.0 million in 2022, then grew by 28.77% to $7.7 million in 2023, then fell by 23.43% to $5.9 million in 2024, then declined by 19.32% to $4.8 million in 2025, then advanced by 12.66% to $5.4 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $5.4 million, $4.8 million, and $12.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Omeros | 1.24 Bn | 1.24 Bn | 27.73 Mn | 6.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.34 Mn |
| Mar 31, 2026 | 5.37 Mn |
| Dec 31, 2025 | 4.76 Mn |
| Sep 30, 2025 | 12.50 Mn |
| Jun 30, 2025 | 8.84 Mn |
| Mar 31, 2025 | 4.41 Mn |
| Dec 31, 2024 | 5.91 Mn |
| Sep 30, 2024 | 7.72 Mn |
| Jun 30, 2024 | 6.50 Mn |
| Mar 31, 2024 | 6.18 Mn |
| Dec 31, 2023 | 7.71 Mn |
| Sep 30, 2023 | 5.87 Mn |
| Jun 30, 2023 | 9.55 Mn |
| Mar 31, 2023 | 6.45 Mn |
| Dec 31, 2022 | 5.99 Mn |
| Sep 30, 2022 | 17.09 Mn |
| Jun 30, 2022 | 10.88 Mn |
| Mar 31, 2022 | 7.35 Mn |
| Dec 31, 2021 | 13.40 Mn |
| Sep 30, 2021 | 10.03 Mn |